CHARACTERISTICS AND PROGNOSIS OF HORMONE RECEPTOR POSITIVE AND HER2 NEGATIVE RECURRENT BREAST CANCER PATIENTS RECEIVING POSTOPERATIVE AROMATASE INHIBITOR

被引:0
|
作者
Mayumi, Ishida [1 ]
Akiko, Igawa [1 ]
Akihiro, Saruwatari [1 ]
Masahiro, Oikawa [1 ]
Chinami, Koga [1 ]
Sumiko, Nishimura [1 ]
Yumiko, Koi [1 ]
Sayuri, Akiyoshi [1 ]
Yoshiaki, Nakamura [1 ]
Shinji, Ohno [1 ]
机构
[1] Kyushu Natl Canc Ctr, Fukuoka, Japan
来源
BREAST | 2013年 / 22卷
关键词
D O I
10.1016/S0960-9776(13)70098-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S48 / S49
页数:2
相关论文
共 50 条
  • [1] Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
    Alvarado-Miranda, Alberto
    Lara-Medina, Fernando Ulises
    Munoz-Montano, Wendy R.
    Zinser-Sierra, Juan W.
    Galeana, Paula Anel Cabrera
    Garza, Cynthia Villarreal
    Benitez, Daniel Sanchez
    Rodriguez, Jesus Alberto Limon
    Salinas, Claudia Haydee Arce
    Guijosa, Alberto
    Arrieta, Oscar
    CURRENT ONCOLOGY, 2023, 30 (07) : 6097 - 6110
  • [2] Triple negative breast cancer compared to hormone receptor negative/HER2 positive breast cancer
    Irfan Cicin
    Hakan Karagol
    Ufuk Usta
    Atakan Sezer
    Sernaz Uzunoglu
    Rusen Alas-Cosar
    Tarkan Yetisyigit
    Kazim Uygun
    Medical Oncology, 2009, 26 : 335 - 343
  • [3] Triple negative breast cancer compared to hormone receptor negative/HER2 positive breast cancer
    Cicin, Irfan
    Karagol, Hakan
    Usta, Ufuk
    Sezer, Atakan
    Uzunoglu, Sernaz
    Alas-Cosar, Rusen
    Yetisyigit, Tarkan
    Uygun, Kazim
    MEDICAL ONCOLOGY, 2009, 26 (03) : 335 - 343
  • [4] Comparison of EndoPredict and MammaPrint in hormone receptor positive, HER2 negative breast cancer
    Boesl, A.
    Spitzmueller, A.
    Haid, A.
    Jasarevic, Z.
    Baruschke, K.
    Jaeger, S.
    Offner, F.
    BREAST, 2015, 24 : S46 - S47
  • [5] Characterization of the tumor microenvironment in patients with hormone receptor positive, HER2 negative early breast cancer
    Kearney, Matthew Ryan
    Vanguri, Rami
    Wang, Qi
    Fenn, Kathleen
    Guo, Hua
    Marks, Douglas
    Hibshoosh, Hanina
    Kalinsky, Kevin M.
    Connolly, Eileen
    CANCER RESEARCH, 2022, 82 (04)
  • [6] Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy
    Mastrantoni, Luca
    Garufi, Giovanna
    Giordano, Giulia
    Maliziola, Noemi
    Di Monte, Elena
    Arcuri, Giorgia
    Frescura, Valentina
    Rotondi, Angelachiara
    Orlandi, Armando
    Carbognin, Luisa
    Palazzo, Antonella
    Miglietta, Federica
    Pontolillo, Letizia
    Fabi, Alessandra
    Gerratana, Lorenzo
    Pannunzio, Sergio
    Paris, Ida
    Pilotto, Sara
    Marazzi, Fabio
    Franco, Antonio
    Franceschini, Gianluca
    Dieci, Maria Vittoria
    Mazzeo, Roberta
    Puglisi, Fabio
    Guarneri, Valentina
    Milella, Michele
    Scambia, Giovanni
    Giannarelli, Diana
    Tortora, Giampaolo
    Bria, Emilio
    NPJ BREAST CANCER, 2025, 11 (01)
  • [7] Protein-protein interaction of HER2 predicts the prognosis of hormone receptor-positive HER2-negative breast cancer
    Choi, Hee Jun
    Lee, Hong Won
    Kim, Sangmin
    Yoon, Tae-Young
    Kim, Hyunwoo
    Lee, Seul
    Nam, Seok Jin
    Kim, Seok Won
    Cho, Sooyoun
    Park, Yeon Hee
    Lee, Jeong Eon
    CANCER RESEARCH, 2020, 80 (04)
  • [8] HDAC inhibitor Tucidinostat plus exemestane as neoadjuvant therapy in patients with hormone receptor positive, HER2 negative breast cancer.
    Wang, Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] The Prognosis of Single Hormone Receptor-Positive Breast Cancer Stratified by HER2 Status
    Zhao, Hengqiang
    Gong, Yiping
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Characteristics and prognosis of patients with primary metastatic disease vs. recurrent HER2-negative, hormone receptor-positive advanced breast cancer
    Walter, Christina B.
    Hartkopf, Andreas D.
    Hein, Alexander
    Fasching, Peter A.
    Kolberg, Hans-Christian
    Hadji, Peyman
    Tesch, Hans
    Haberle, Lothar
    Ettl, Johannes
    Luftner, Diana
    Wallwiener, Markus
    Muller, Volkmar
    Beckmann, Matthias W.
    Michel, Laura L.
    Belleville, Erik
    Huebner, Hanna
    Uhrig, Sabrina
    Goossens, Chloe
    Wimberger, Pauline
    Hielscher, Carsten
    Meyer, Julia
    Mundhenke, Christoph
    Kurbacher, Christian
    Untch, Michael
    Janni, Wolfgang
    Taran, Florin-Andrei
    Lux, Michael P.
    Wallwiener, Diethelm
    Brucker, Sara Y.
    Schneeweiss, Andreas
    Fehm, Tanja N.
    Wuerstlein, Rachel
    Fremd, Carlo
    BREAST, 2025, 80